Anzeige
Mehr »
Dienstag, 05.08.2025 - Börsentäglich über 12.000 News
Warum Guardian Metal die Pentagon-gestützte Antwort auf Chinas Dominanz ist
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
16.07.Bankrupt Nostrum Labs recalls ulcer drug after shutting down operations
16.07.Real Chemistry finds its formula, adding a trio of new execs as catalysts for change
16.07.Amphastar lays out plan to quadruple manufacturing capacity at its California HQ
15.07.GSK expands Medicines Patent Pool deal to allow generic production of cabotegravir for HIV treatment
15.07.Consumer health giant Kenvue kicks off CEO transition as sales slip
15.07.As GSK eyes Blenrep's US return, FDA flags eye safety concerns ahead of advisory committee meeting
15.07.As Perrigo's streamlining takes shape, self-care specialist offloads OTC dermatology unit for up to €327M
14.07.China biotechs 'reshaping' US biopharma as outlicensing deals rise 11%: Jefferies report
14.07.Humana kicks off virtual brain health challenge ahead of National Senior Games
14.07.Sun Pharma's alopecia med Leqselvi hits US market after Incyte patent settlement
14.07.BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis
14.07.Formulation specialist Azurity to lay off 75 amid plans to sunset Massachusetts plant
14.07.Ultragenyx takes another hit as FDA snubs AAV gene therapy over manufacturing issues
14.07.Varda reels in $187M series C to propel drug manufacturing in space
14.07.Bayer's Kerendia wins FDA label expansion to treat certain patients with heart failure
14.07.On heels of Gilead deal, Leo pays Boehringer Ingelheim €90 million up front for Spevigo
11.07.The advantages of lab-based RWD for precise HCP identification
11.07.Zantac drugmakers notch key win in Delaware as court tosses expert testimony for plaintiffs
11.07.Karyopharm lays off more workers as hunt for strategic alternatives turns up short
11.07.Bayer scores first approval for hormone-free menopause drug Lynkuet in UK
11.07.Jazz hits a sour note in back-to-back rebukes from UK marketing watchdog
11.07.Non-opioid pain drug maker Pacira lays off 71 in California, retires facility in manufacturing upgrade
11.07.'Weak evidence' and an 'unpleasant' odor: FDA sheds light on drug refusal process
10.07.State AGs unveil opioid settlements totaling $720M with 8 drugmakers
10.07.Astellas reports 22% sales bump for Izervay, expects trend to continue this year